FDA Inspection 1333132 — 23andMe Genomics LLC
The FDA completed an inspection of 23andMe Genomics LLC on Aug 21, 2026 in Palo Alto, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 21, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Palo Alto, CA (United States)